Company Profiles

driven by the PitchBook Platform

American Gene Technologies International

Description

Developer of bio-safe, high efficiency lentivirus therapies to treat cancer and other chronic human diseases. The company’s products incorporate a novel, proprietary technology for the clinical application of gene expression technology in cancer therapy, autosomal disorders, stem cell treatment, and other applications.

2007

Founded

PRIVATE

Status

11-50

Employees

Later Stage VC

Latest Deal Type

$1.16M

Latest Deal Amount

$2.83M

Total Amount Raised

Description

Developer of bio-safe, high efficiency lentivirus therapies to treat cancer and other chronic human diseases. The company’s products incorporate a novel, proprietary technology for the clinical application of gene expression technology in cancer therapy, autosomal disorders, stem cell treatment, and other applications.

Website:

www.americangene.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Pharmaceuticals

Primary Office

15010 Broschart Road Suite 110 Rockville, MD 20850United States +1 (301) 337-2100
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore American Gene Technologies International's full profile, request a free trial.

American Gene Technologies International Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

American Gene Technologies International Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

American Gene Technologies International Executive Team (4)

NameTitleBoard
Seat
Contact
Info
Jeffrey GalvinCo-Founder & Chief Executive Officer
John MatthewsChief Strategy Officer
David PauzaChief Science Officer
Dan Sussman Ph.DVice President of Research & Development
Jeffrey Galvin Co-Founder & Chief Executive Officer
John Matthews Chief Strategy Officer
David Pauza Chief Science Officer
Dan Sussman Ph.D Vice President of Research & Development

American Gene Technologies International Board Members (2)

NameRepresentingRoleSinceContact
Info
Stuart BakerAmerican Gene Technologies InternationalBoard Member000 0000
Tommy Thompson JDSelfBoard Member000 0000
Stuart Baker Board Member American Gene Technologies International
Tommy Thompson JD Board Member Self
Request full access to PitchBook